The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial

The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial

Abstract Background To compare glycemic control in Chinese patients with type 2 diabetes mellitus (T2DM) whose blood glucose levels were inadequately controlled with oral antidiabetic drugs after beinaglutide alone or combined with insulin glargine (IGlar). Methods In this 16‐week multicenter, rando...

Full description

Bibliographic Details
Main Authors: Xiangyang Liu, Wenjuan Yang, Jianrong Liu, Xinxi Huang, Yujie Fang, Jie Ming, Jingbo Lai, Jianfang Fu, Qiuhe Ji, Li Wang
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Journal of Diabetes
Subjects:
beinaglutide
fasting C‐peptide
insulin glargine (IGlar)
Online Access:https://doi.org/10.1111/1753-0407.13483

Internet

https://doi.org/10.1111/1753-0407.13483

Similar Items